Gammavision Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.70 M
as on 04-07-2024
- Paid Up Capital ₹ 0.65 M
as on 04-07-2024
- Company Age 22 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.38 Cr
as on 04-07-2024
- Revenue 5.59%
(FY 2022)
- Profit 5.49%
(FY 2022)
- Ebitda 9.23%
(FY 2022)
- Net Worth 59.28%
(FY 2022)
- Total Assets 10.96%
(FY 2022)
About Gammavision Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.70 M and a paid-up capital of Rs 0.65 M.
The company has closed loans amounting to ₹3.38 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Nitin Ketkar, Milind Bichkar, Kedar Bhate, and Eight other members serve as directors at the Company.
- CIN/LLPIN
U85110PN2002PTC017458
- Company No.
017458
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gammavision Diagnostics?
Board Members(11)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Ketkar  | Director | 13-Jan-2003 | Current |
| Milind Bichkar | Director | 01-Oct-2007 | Current |
| Kedar Bhate | Director | 28-Nov-2002 | Current |
| Shrikant Gundawar | Director | 13-Jan-2003 | Current |
| Vijay Kadam | Director | 13-Jan-2003 | Current |
| Madhav Kulkarni | Director | 13-Jan-2003 | Current |
Financial Performance of Gammavision Diagnostics.
Gammavision Diagnostics Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 5.59% increase. The company also saw a slight improvement in profitability, with a 5.49% increase in profit. The company's net worth Soared by an impressive increase of 59.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gammavision Diagnostics?
In 2020, Gammavision Diagnostics had a promoter holding of 8.33% and a public holding of 91.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sanrad Medical Systems Private LimitedActive 13 years 9 monthsRatishchandran Nair is a mutual person
Gyro Scanning Services Private LimitedActive 27 years 9 monthsNitin Ketkar, Milind Bichkar and 9 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Siemens Financial Services Private Limited Creation Date: 18 Sep 2015 | ₹1.39 Cr | Satisfied |
Shree Sharada Sahakari Bank Limited. Creation Date: 16 Mar 2013 | ₹6.90 M | Satisfied |
Shree Sharada Sahakari Bank Ltd. Creation Date: 29 Jul 2008 | ₹7.00 M | Satisfied |
How Many Employees Work at Gammavision Diagnostics?
Unlock and access historical data on people associated with Gammavision Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gammavision Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gammavision Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
